Given our data regarding the correlation between NSE level and MM condition changes and in consideration of the above-mentioned studies abroad, we propose that serum NSE levels in patients with multiple myeloma can be increased to varying degrees. The gene discussed is ENO2; the disease is Miyoshi myopathy.